Your browser doesn't support javascript.
loading
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis.
Alsouqi, Aseel; Ahmed, Gulrayz; Wang, Juntian; Cassanello, Giulio; Szabo, Aniko; Rojek, Alexandra E; Riedell, Peter A; Awan, Farrukh; Samples, Laura; Shadman, Mazyar; Hu, Marie; Bachanova, Veronika; Wesson, William; Ahmed, Nausheen; Iqbal, Madiha; Kharfan-Dabaja, Mohamed A; Scordo, Michael; Johnson, P Connor; Chen, Yi-Bin; Ito, Sawa; Hamadani, Mehdi; Frigault, Matthew.
Afiliación
  • Alsouqi A; Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Ahmed G; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Wang J; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Cassanello G; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Szabo A; Department of Oncology and Onco-hematology, University of Milan, Milan, Italy.
  • Rojek AE; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA.
  • Awan F; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA.
  • Samples L; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Hu M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
  • Wesson W; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
  • Ahmed N; Division of Hematologic Malignancies and Cellular Therapy, University of Kansas Cancer Center, Kansas City, Kansas, USA.
  • Iqbal M; Division of Hematologic Malignancies and Cellular Therapy, University of Kansas Cancer Center, Kansas City, Kansas, USA.
  • Kharfan-Dabaja MA; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Scordo M; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Johnson PC; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital - Harvard Medical School, Boston, Massachusetts, USA.
  • Ito S; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital - Harvard Medical School, Boston, Massachusetts, USA.
  • Hamadani M; Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Frigault M; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Am J Hematol ; 99(8): 1624-1627, 2024 08.
Article en En | MEDLINE | ID: mdl-38769663
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Neoplasias del Sistema Nervioso Central / Receptores Quiméricos de Antígenos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Neoplasias del Sistema Nervioso Central / Receptores Quiméricos de Antígenos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos